electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
Rhea-AI Summary
electroCore (Nasdaq: ECOR) will present at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub at the Bellagio in Las Vegas.
Interim President and CFO Joshua Lev will give a company presentation and host one-on-one investor meetings, with a webcast and recent strategy video available online.
Positive
- None.
Negative
- None.
News Market Reaction – ECOR
On the day this news was published, ECOR declined 8.70%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.0% during that session. Argus tracked a trough of -12.0% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $8M from the company's valuation, bringing the market cap to $83.29M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 13 | Clinical trial publication | Positive | -5.6% | JAMA Network Open fibromyalgia trial showed durable pain and fatigue improvements. |
| May 08 | Investor conference | Neutral | +3.1% | LD Micro Invitational presentation and one-on-one investor meetings with webcast. |
| May 06 | Earnings results | Negative | -5.9% | Q1 2026 sales growth with high margin but losses and revenue-growth guidance reaffirmed. |
| Apr 30 | Product recognition | Positive | +5.8% | TAC-STIM named national semifinalist in safety innovation challenge and NSC Summit exposure. |
| Apr 29 | Earnings date notice | Neutral | +0.0% | Announcement of timing and webcast details for upcoming Q1 2026 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Stock has often reacted sharply to mixed fundamentals and product or recognition news, with one notable selloff on positive clinical data.
Over the last few months, ECOR reported Q1 2026 net sales of $9.6 million with an 87% gross margin but a GAAP net loss of $5.3 million and disclosed going-concern risk. Product and recognition updates, such as TAC-STIM’s national semifinalist status, have coincided with positive moves. Conference-related visibility, including the LD Micro Invitational in May 2026, previously saw a modest gain. Today’s Planet MicroCap appearance continues this pattern of investor-outreach events alongside mixed but growing fundamentals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort & Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.
Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:
Dates: June 17 - 18, 2026
Company Presentation: Wednesday, June 17 at 10:30 am PT
Location: Bellagio Resort & Casino, Las Vegas, NV Webcast: https://event.summitcast.com/view/bpjo3VVjZ25pp6SXpUua92/4CSAXUYpH7cP7oqVpDE3sB
Investors may also access a recent video interview featuring Joshua Lev with Robert Kraft discussing the Company’s strategy and growth opportunities here:
https://www.youtube.com/watch?v=TtuSgTQ2gWE
If you would like to book one-on-one investor meetings with electroCore and attend Planet MicroCap Las Vegas 2026, please register at https://planetmicrocapshowcase.com/.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
About Planet MicroCap
Planet MicroCap hosts high-quality microcap investor conferences and events focused on connecting public companies, investors, and industry professionals. For more information about Planet MicroCap, please visit: https://planetmicrocap.com/
About MicroCapClub
MicroCapClub is an exclusive forum for experienced microcap investors to share and discuss microcap companies trading on global markets. Since 2011, members have profiled more than 1,500 microcap companies, with more than 300 becoming multi-baggers. For more information, visit https://microcapclub.com/
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
